A new class of synthetic substances is causing alarm amongst public health officials worldwide. Nitazenes, which are reportedly 40 times more powerful than fentanyl, have emerged as a significant threat to communities across the United States, Europe, and Australia.

These synthetic opioids were originally developed in the 1950s by an Austrian pharmaceutical company but were never approved for medical use. Their reappearance in illegal markets has led to hundreds of confirmed deaths across multiple continents since 2019, though experts believe the true figure is considerably higher.

Understanding the Extreme Potency

Fentanyl itself is already 50 times more powerful than heroin, making it one of the most dangerous substances in circulation. However, nitazenes are stronger than fentanyl, representing an unprecedented level of danger for users. This extreme potency means individuals often have no idea of the risks they’re facing when consuming adulterated drugs.

Drug dealers have begun cutting other substances with these synthetic opioids to increase their profits, putting unsuspecting people at severe risk. Law enforcement first detected these substances around 2019 when a shipment of isotonitazene was intercepted in the American Midwest. Since then, deaths linked to these ultra-potent drugs have been reported throughout multiple countries.

Why Dealers Are Using These Substances

The appeal to illegal manufacturers becomes clear when examining the potency levels. With nitazenes stronger than fentanyl, smaller quantities can produce the same effects, making them cost-effective for production and distribution. Additionally, these substances initially flew under the regulatory radar, as authorities had largely forgotten about them for decades.

Illegal laboratories have reportedly accessed historical chemical formulas from old pharmacology textbooks to synthesise these drugs, whilst also developing new variants. In America, these substances are manufactured both domestically and in Mexico, with raw materials often supplied by Asian sources.

The Changing Global Drug Landscape

The emergence of these ultra-powerful synthetic opioids coincides with significant shifts in global drug markets. In the United States, synthetic opioids already account for approximately 70 per cent of the 105,000 overdose deaths recorded in 2023, with fentanyl being the most prevalent. Now, with nitazenes stronger than fentanyl entering circulation, the crisis threatens to worsen considerably.

Europe faces a different dynamic. Historically dominated by heroin from Afghanistan, the European market experienced disruption when the Taliban banned opium poppy cultivation in 2021. As heroin stockpiles diminish, these synthetic drugs could fill the resulting gap, fundamentally altering the continent’s drug landscape.

The Multiplied Dangers

What makes these substances particularly hazardous is how little is understood about them. Like all opioids, they produce feelings of relaxation and euphoria, but they also cause respiratory depression—a condition where breathing becomes dangerously shallow, potentially leading to fatal overdoses.

The potency difference is staggering. Even microscopic amounts can prove lethal when dealing with such powerful substances. Each variant has different strength levels and pharmacokinetic properties, meaning how they’re absorbed and metabolised remains largely mysterious. This unpredictability makes it extremely difficult to anticipate the body’s response, even for medical professionals attempting to treat overdoses.

These substances are highly addictive and were never properly studied in humans, having been quickly dismissed as unsuitable for medical applications decades ago. This lack of research now poses serious challenges for developing effective interventions.

A Crisis That’s Rapidly Escalating

Public health experts have recently issued urgent calls for increased monitoring and intervention strategies. The trajectory mirrors the devastating rise of fentanyl deaths seen in previous years, but the arrival of these more potent synthetic opioids suggests overdose rates could climb even higher without decisive action.

Deaths linked to these drugs have now been confirmed across three continents—the United States, multiple European nations, and Australia. The rapid geographical spread demonstrates how quickly new threats can emerge in an interconnected world.

Why Standard Harm Reduction May Not Be Enough

The extreme potency raises serious questions about existing harm reduction strategies. Naloxone, the overdose reversal medication, may require multiple doses when dealing with such powerful substances. Emergency responders are being trained to recognise that standard protocols may need adjustment when nitazenes more potent than fentanyl are suspected.

Enhanced testing capabilities are essential, as identifying these synthetic opioids requires specific procedures not routinely performed. Many users believe they’re consuming heroin or standard fentanyl, completely unaware they’re exposed to something far more dangerous.

The Importance of Awareness and Prevention

Addressing this crisis requires coordinated international efforts and public awareness. Understanding the existence and dangers of these ultra-potent substances is crucial for anyone who might encounter them, whether directly or through supporting others.

The situation highlights the evolving nature of substance misuse challenges. As one drug becomes regulated or scarce, manufacturers simply pivot to alternatives—often making them more dangerous in the process. The fact that these new synthetic opioids possess such extreme potency means even tiny miscalculations can prove fatal.

The spread of these substances across multiple continents demonstrates the need for comprehensive approaches. Education about the risks, accessible support services, and evidence-based harm reduction strategies remain vital tools for protecting communities. Early intervention and prevention are the most effective approaches for addressing this growing threat to public health.

Source: Wired